Skip to main content
Terug
Watch Compare

RenovoRx, Inc.

Datakwaliteit: 100%
RNXT
Nasdaq Manufacturing Chemicals
€ 0,99
▲ € 0,01 (0,71%)
Marktkapitalisatie: 46,81 M
Prijs
€ 0,99
Marktkapitalisatie
46,81 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Negative free cash flow of -10,98 M
Capital efficient — spends only 0,18% of revenue on capex

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)2511,63%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-119,32%
Onder sectorgemiddelde (-53,34%)
ROIC-92,32%
Net Margin-994,48%
Op. Margin-1113,98%

Veiligheid

Debt / Equity
N/A
Current Ratio5,83
Interest CoverageN/A

Waardering

PE (TTM)
-4,19
Onder sectorgemiddelde (-1,47)
P/B Ratio5,79
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -4,2 -1,5
P/B 5,8 1,6
ROE % -119,3 -53,3
Net Margin % -994,5 -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Koersdoel Analisten

4 analisten
Buy
Huidig
€ 0,99
+597.8%
Koersdoel
€ 6,88
€ 3,00
€ 5,50
€ 13,50
Vooruitzicht
Forward K/W -15,16
Forward WPA -€ 0,07
Omzet Sch. 14,93 M

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 0,07
-€ 0,13 – € 0,00
 14,93 M 2
FY2026 -€ 0,29
-€ 0,35 – -€ 0,25
 3,41 M 3

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 0,08 -€ 0,08 0,0%
Q32025 -€ 0,08 -€ 0,08 0,0%
Q22025 -€ 0,08 -€ 0,08 0,0%
Q12025 -€ 0,08 -€ 0,08 -6,7%

All Fundamental Metrics
Growth
Revenue Growth (1Y) 2511,63% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1,12 M Net Income (TTM) -11,17 M
ROE -119,32% ROA -89,89%
Gross Margin 70,88% Operating Margin -1113,98%
Net Margin -994,48% Free Cash Flow (TTM) -10,98 M
ROIC -92,32% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 5,83
Interest Coverage N/A Asset Turnover 0,09
Working Capital 9,10 M Tangible Book Value 8,08 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4,19 Forward P/E N/A
P/B Ratio 5,79 P/S Ratio 41,68
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -23,45%
Market Cap 46,81 M Enterprise Value 36,77 M
Per Share
EPS (Diluted TTM) -0,32 Revenue / Share 0,02
FCF / Share -0,23 OCF / Share -0,23
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,18% FCF Conversion 98,27%
SBC-Adj. FCF -12,21 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1,12 M 43.000,0 — — —
Net Income -11,17 M -8,81 M -10,23 M -9,89 M -6,32 M
EPS (Diluted) -0,32 -0,40 -0,99 — —
Gross Profit 796.000,0 43.000,0 — — —
Operating Income -12,51 M -10,97 M -11,40 M -9,95 M -5,67 M
EBITDA — — — — —
R&D Expenses 6,27 M 6,03 M 5,67 M 4,30 M 3,04 M
SG&A Expenses 7,04 M 4,99 M — — —
D&A 2,00 M — — — —
Interest Expense — — — — -834.000,0
Income Tax 2.000,0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 8,10 M 8,12 M 1,47 M 7,27 M 16,29 M
Total Liabilities 2,67 M 3,64 M 4,47 M 1,10 M 938.000,0
Shareholders' Equity 5,42 M 4,48 M -3,00 M 6,16 M 15,35 M
Total Debt — — — — —
Cash & Equivalents 7,02 M 7,15 M 1,17 M 4,39 M 15,19 M
Current Assets 7,89 M 7,83 M — 7,27 M 16,28 M
Current Liabilities 1,96 M 1,91 M 1,18 M — 938.000,0